170 related articles for article (PubMed ID: 14555562)
1. Airway responsiveness to adenosine 5'-monophosphate and exhaled nitric oxide measurements: predictive value as markers for reducing the dose of inhaled corticosteroids in asthmatic subjects.
Prieto L; Bruno L; Gutiérrez V; Uixera S; Pérez-Francés C; Lanuza A; Ferrer A
Chest; 2003 Oct; 124(4):1325-33. PubMed ID: 14555562
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of the response to inhaled adenosine 5'-monophosphate for reducing the dose of inhaled corticosteroids in asthma.
Prieto L; Ferrer A; Domenech J; López V; Marin J
J Investig Allergol Clin Immunol; 2013; 23(5):351-8. PubMed ID: 24260981
[TBL] [Abstract][Full Text] [Related]
3. Exhaled nitric oxide measurement is not useful for predicting the response to inhaled corticosteroids in subjects with chronic cough.
Prieto L; Ferrer A; Ponce S; Palop J; Marín J
Chest; 2009 Sep; 136(3):816-822. PubMed ID: 19411296
[TBL] [Abstract][Full Text] [Related]
4. Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction.
Luijk B; Kempsford RD; Wright AM; Zanen P; Lammers JW
Eur Respir J; 2004 Apr; 23(4):559-64. PubMed ID: 15083754
[TBL] [Abstract][Full Text] [Related]
5. Association of symptom control with changes in lung function, bronchial hyperresponsiveness, and exhaled nitric oxide after inhaled corticosteroid treatment in children with asthma.
Park GM; Han HW; Kim JY; Lee E; Cho HJ; Yoon J; Hong SJ; Yang SI; Yang HJ; Yu J
Allergol Int; 2016 Oct; 65(4):439-443. PubMed ID: 27160342
[TBL] [Abstract][Full Text] [Related]
6. Correlation between reversibility of airway obstruction and exhaled nitric oxide levels in children with stable bronchial asthma.
Colon-Semidey AJ; Marshik P; Crowley M; Katz R; Kelly HW
Pediatr Pulmonol; 2000 Nov; 30(5):385-92. PubMed ID: 11064429
[TBL] [Abstract][Full Text] [Related]
7. Repeated dosing effects of mediator antagonists in inhaled corticosteroid-treated atopic asthmatic patients.
Lee DK; Jackson CM; Haggart K; Lipworth BJ
Chest; 2004 Apr; 125(4):1372-7. PubMed ID: 15078748
[TBL] [Abstract][Full Text] [Related]
8. Modifications of airway responsiveness to adenosine 5'-monophosphate and exhaled nitric oxide concentrations after the pollen season in subjects with pollen-induced rhinitis.
Prieto L; Uixera S; Gutiérrez V; Bruno L
Chest; 2002 Sep; 122(3):940-7. PubMed ID: 12226036
[TBL] [Abstract][Full Text] [Related]
9. Exhaled nitric oxide predicts loss of asthma control in children after inhaled corticosteroids withdrawal.
Chang DV; Teper A; Balinotti J; Castro Simonelli C; Garcia-Bournissen F; Kofman C
Pediatr Pulmonol; 2019 May; 54(5):537-543. PubMed ID: 30688035
[TBL] [Abstract][Full Text] [Related]
10. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship.
Jones SL; Herbison P; Cowan JO; Flannery EM; Hancox RJ; McLachlan CR; Taylor DR
Eur Respir J; 2002 Sep; 20(3):601-8. PubMed ID: 12358335
[TBL] [Abstract][Full Text] [Related]
11. Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis.
Wang K; Verbakel JY; Oke J; Fleming-Nouri A; Brewin J; Roberts N; Harada N; Atsuta R; Takahashi K; Mori K; Fujisawa T; Shirai T; Kawayama T; Inoue H; Lazarus S; Szefler S; Martinez F; Shaw D; Pavord ID; Thomas M
Eur Respir J; 2020 May; 55(5):. PubMed ID: 32139458
[TBL] [Abstract][Full Text] [Related]
12. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids.
Leuppi JD; Salome CM; Jenkins CR; Anderson SD; Xuan W; Marks GB; Koskela H; Brannan JD; Freed R; Andersson M; Chan HK; Woolcock AJ
Am J Respir Crit Care Med; 2001 Feb; 163(2):406-12. PubMed ID: 11179114
[TBL] [Abstract][Full Text] [Related]
13. Maximal response plateau to adenosine 5'-monophosphate in asthma. Relationship with the response to methacholine, exhaled nitric oxide, and exhaled breath condensate pH.
Prieto L; Esnal S; Lopez V; Barato D; Rojas R; Marín J
Chest; 2009 Jun; 135(6):1521-1526. PubMed ID: 19225062
[TBL] [Abstract][Full Text] [Related]
14. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma.
Sandrini A; Ferreira IM; Gutierrez C; Jardim JR; Zamel N; Chapman KR
Chest; 2003 Oct; 124(4):1334-40. PubMed ID: 14555563
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Chest; 2001 Apr; 119(4):1021-6. PubMed ID: 11296164
[TBL] [Abstract][Full Text] [Related]
16. Exhaled nitric oxide continues to reflect airway hyperresponsiveness and disease activity in inhaled corticosteroid-treated adult asthmatic patients.
Reid DW; Johns DP; Feltis B; Ward C; Walters EH
Respirology; 2003 Dec; 8(4):479-86. PubMed ID: 14629652
[TBL] [Abstract][Full Text] [Related]
17. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
[TBL] [Abstract][Full Text] [Related]
18. Effect of inhaled steroid therapy on exhaled nitric oxide and bronchial responsiveness in children with asthma.
Nishio K; Odajima H; Motomura C; Nakao F; Nishima S
J Asthma; 2006 Dec; 43(10):739-43. PubMed ID: 17169825
[TBL] [Abstract][Full Text] [Related]
19. Exhaled nitric oxide and bronchial responsiveness to adenosine 5'-monophosphate in subjects with allergic rhinitis.
Prieto L; Gutiérrez V; Uixera S
Chest; 2002 Jun; 121(6):1853-9. PubMed ID: 12065349
[TBL] [Abstract][Full Text] [Related]
20. Exhaled nitric oxide as a predictor of exacerbation in children with moderate-to-severe asthma: a prospective, 5-month study.
Cabral AL; Vollmer WM; Barbirotto RM; Martins MA
Ann Allergy Asthma Immunol; 2009 Sep; 103(3):206-11. PubMed ID: 19788017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
